Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1746-1596

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer ; volume:15 ; number:1 ; day:17 ; month:4 ; year:2020 ; pages:1-6 ; date:12.2020
Diagnostic pathology ; 15, Heft 1 (17.4.2020), 1-6, 12.2020

Creator: Jasani, Bharat
Bänfer, Gudrun
Fish, Rebecca
Waelput, Wim
Sucaet, Yves
Barker, Craig
Whiteley, Jessica L.
Walker, Jill
Hovelinck, Rudy
Diezko, Rolf

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13000-020-00953-9

URN: urn:nbn:de:101:1-2020062920090604701539

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jasani, Bharat
Bänfer, Gudrun
Fish, Rebecca
Waelput, Wim
Sucaet, Yves
Barker, Craig
Whiteley, Jessica L.
Walker, Jill
Hovelinck, Rudy
Diezko, Rolf
SpringerLink (Online service)

Other Objects (12)

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Optimized PD-L1 scoring of gastric cancer

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

PD-L1 degradation pathway and immunotherapy for cancer

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Clinical applications of PD-L1 bioassays for cancer immunotherapy

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy

Related objects

Reset password